| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.74B | $4.55B | $3.93B |
| YoY Revenue Growth % | +26.2% | +15.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$79.0M | -$56.0M | $39.0M |
| Operating Margin % | -1.4% | -1.2% | 1.0% |
| Net Income (GAAP) | -$100.0M | -$290.0M | $4.0M |
| EBITDA (Normalized) | -$31.8M | -$20.0M | $180.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $51.0M | -$12.0M | $89.0M |
| Capital Expenditures (CapEx) | $59.0M | $45.0M | $176.7M |
| Free Cash Flow (FCF) | -$8.0M | -$57.0M | -$87.7M |
| FCF Margin % | -0.1% | -1.3% | -2.2% |
| Return on Invested Capital (ROIC %) | -2.7% | -1.9% | 1.1% |
| Cash & Short-Term Equivalents | $17.0M | $35.0M | — |
| Total Debt (Short + Long Term) | $766.8M | $798.9M | $1.10B |
| Total Stockholders' Equity | $1.54B | $1.61B | $2.26B |